1 Lauterbur DriveStony Brook, NY 11794
Overview of Dr. Sher
Dr. Amna Sher is an oncologist based in Stony Brook, NY, with a background in hematology and medical oncology from Stony Brook Medicine/University Hospital, where she completed her fellowship and residency. A graduate of Fatima Jinnah Medical College, she has professional experience with esophageal cancer. Her research work includes multiple publications, such as analyses on non-small cell lung cancer and the effects of pembrolizumab and bevacizumab, with articles appearing in journals like Cancer Management and Research, Cancer Investigation, and Acta Oncologica. Her publications have been cited by other sources, contributing to the field of oncology research.
Education & Training
Stony Brook Medicine/University HospitalFellowship, Hematology and Medical Oncology, 2012 - 2015- Stony Brook Medicine/University HospitalResidency, Internal Medicine, 2008 - 2011
Fatima Jinnah Medical CollegeClass of 2005
Certifications & Licensure
NY State Medical License 2012 - 2028
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3 citationsRisk Stratification of Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Chemo-Radiotherapy: An Institutional Analysis.Amna Falak Sher, Sowmini Medavaram, Barbara Nemesure, Sean Clouston, Roger Keresztes
Cancer Management and Research. 2020-08-11 - 6 citationsAnti-PD-1-Related Exacerbation of Interstitial Lung Disease in a Patient with Non-Small Cell Lung Cancer: A Case Presentation and Review of the Literature.Julie Anne L Gemmill, Amna Falak Sher
Cancer Investigation. 2020-07-02 - 14 citationsFatal Adverse Events Associated with Pembrolizumab in Cancer Patients: A Meta-AnalysisAmna Falak Sher, Gol Minoo Golshani, Shenhong Wu
Cancer Investigation. 2020-02-05
Press Mentions
Oncologists Are Begging People to Take This One Common Cancer Risk Factor SeriouslyFebruary 8th, 2026- These Early Signs of Lung Cancer Are Often Missed, Oncologists SaySeptember 27th, 2024
- The #1 Commonly Missed Early Sign of Lung Cancer, According to OncologistsSeptember 11th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
